Evexta Bio, is a biopharmaceutical enterprise venturing into the uncharted territories of oncology, seeking innovative therapeutic approaches with the potential to revolutionize patient outcomes. Presently advancing through clinical stages, this French biotech is actively developing two proprietary therapeutic candidates, each harboring novel mechanisms of action and targeting multiple indications. Founded with backing from Tr...
Evexta Bio, is a biopharmaceutical enterprise venturing into the uncharted territories of oncology, seeking innovative therapeutic approaches with the potential to revolutionize patient outcomes. Presently advancing through clinical stages, this French biotech is actively developing two proprietary therapeutic candidates, each harboring novel mechanisms of action and targeting multiple indications. Founded with backing from Truffle Capital, Evexta Bio has cultivated partnerships with esteemed entities in both academia and industry, including CNRS, the Paoli-Calmettes Institute in Marseille, France, and Merck KGaA in Darmstadt, Germany.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.